Trade groups are urging the administration to consider the impact on patient care and are pushing for exemptions to the tariffs. Also in the news: Pfizer might move production to the U.S. to combat ...

China will refine its centralized drug procurement policy following a probe into off-patent medicine quality, aiming to ...

The results are in, and during the first quarter of the 21st century by far the biggest beneficiary has been the Asia-Pacific ...